Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Alexandra PustaDepartment of Analytical Chemistry and Instrumental Analysis, Iuliu Hațieganu University of Medicine and Pharmacy, 4 Pasteur Street, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-7789-6798
Mihaela TertisDepartment of Analytical Chemistry and Instrumental Analysis, Iuliu Hațieganu University of Medicine and Pharmacy, 4 Pasteur Street, 400349 Cluj-Napoca, Romania.ORCID 0000-0003-2572-6724
Bianca CiocanDepartment of Analytical Chemistry and Instrumental Analysis, Iuliu Hațieganu University of Medicine and Pharmacy, 4 Pasteur Street, 400349 Cluj-Napoca, Romania.
Rodica TurcuNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Street, 400293 Cluj-Napoca, Romania.ORCID 0000-0002-6355-8381
Izabell CrăciunescuNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donat Street, 400293 Cluj-Napoca, Romania.
Victor C DiculescuNational Institute of Materials Physics, 405A Atomiştilor Street, 077125 Măgurele, Romania.ORCID 0000-0003-0719-8016
George E StanNational Institute of Materials Physics, 405A Atomiştilor Street, 077125 Măgurele, Romania.ORCID 0000-0003-0289-8988
Stefan BulatNational Institute of Materials Physics, 405A Atomiştilor Street, 077125 Măgurele, Romania.
Alina PorfireDepartment of Pharmaceutical Technology and Biopharmaceutics, Iuliu Hațieganu University of Medicine and Pharmacy, 41 Victor Babeş Street, 400012 Cluj-Napoca, Romania.
Andreea-Elena PetruDepartment of Toxicology, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babeş, Street, 400012 Cluj-Napoca, Romania.
Ionel FizeșanDepartment of Toxicology, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babeş, Street, 400012 Cluj-Napoca, Romania.
Simona MirelDepartment of Medical Devices, Iuliu Hațieganu University of Medicine and Pharmacy, 4 Pasteur Street, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-6318-3826
Cecilia CristeaDepartment of Analytical Chemistry and Instrumental Analysis, Iuliu Hațieganu University of Medicine and Pharmacy, 4 Pasteur Street, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-4158-3324
Funding
Romanian Ministry of Education and Research, CNCS UEFISCDI, PN-IV-P1-PCE-2023-1104; PN23240103; PC1-PN23080101.1
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
aptamershepatocellular carcinomamagnetic nanoparticlessorafenibtargeted drug delivery
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Aptamer-Modified Magnetic Nanoparticles as Targeted Drug Delivery Systems for Hepatocellular Carcinoma. · full record | OpenQuestion